Dr. Becich is Professor and Chairman of the Department of Biomedical Informatics at the University of Pittsburgh School of Medicine. He is jointly appointed in Pathology, Information Sciences/Telecommunications and Clinical/Translational Research. He is Associate Director of the University of Pittsburgh Cancer Institute and Co-Director of the Clinical and Translational Science Institute at the University of Pittsburgh School of Medicine. Dr. Becich obtained his MD and a PhD in Experimental Pathology from Northwestern University, and served as a staff anatomic pathologist after completing his pathology residency at Washington University School of Medicine (St. Louis, MO). At the University of Pittsburgh School of Medicine he founded the nation's first Pathology Informatics fellowship program and the Advancing Practice Instruction and Innovation through Informatics (APIII) conference which now has been renamed as Pathology Informatics 20XX. In 2000, in partnership with Bruce Friedman, MD, he helped co-found the Association for Pathology Informatics. He is a member of 14 professional societies and has contributed to over 150 papers as well as several on-line presentations. He is a fellow of the College of American Pathologists and the American College of Medical Informatics. Dr. Becich's research interests are focused on the interface between clinical informatics imaging informatics and bioinformatics. His research is funded by the NCI, NCRR, NLM, CDC, TATRC and the DOD and includes clinical phenotyping of patients for genomic studies, tissue banking informatics and bioinformatics with a special emphasis on data sharing. Dr. Becich is a member of the Scientific Advisory Board of Omnyx and has been an innovator and entrepreneur in the area of whole slide imaging and digital pathology and their use in improving patient care and patient safety. A complete online profile including bibliography is available at www.dbmi.pitt.edu/person/michael-j-becich-md-phd.
Brett Bouma is a co-inventor of NinePoint Medical’s optical imaging technology. He is a professor of dermatology and health sciences and technology at Harvard Medical School and an associate physicist at the Wellman Center for Photomedicine at Massachusetts General Hospital. Brett’s research on optical technology has contributed to the development of imaging modalities such as optical coherence tomography, spectrally encoded confocal microscopy, and spectrally encoded endoscopy. A prolific author and coauthor of professional papers, scientific abstracts, and book chapters, he is a fellow of the Optical Society of America. He received a BS degree in physics from Hope College, an MS degree in physics from Michigan State University, and a PhD degree in physics from the University of Illinois, Chicago.
Dr. Sanjiv Sam Gambhir is the Virginia and D.K. Ludwig Professor of Cancer Research and the Chair of Radiology at Stanford University School of Medicine. He also heads up the Canary Center at Stanford for Cancer Early Detection. He received his MD/PhD from the UCLA Medical Scientist Training Program. He has over 400 publications in the field and over 40 patents pending or granted. An internationally recognized researcher in molecular imaging with over $75 Million of NIH funding as the PI, his lab has focused on interrogating fundamental molecular events in living subjects. He has developed and clinically translated several multimodality molecular imaging strategies including imaging of gene and cell therapies. He has also developed strategies for Raman and Photoacoustic molecular imaging. He serves as an advisor to several companies including General Electric Medical Systems and Bayer-Schering and has also co-founded several imaging startups.
He serves on numerous academic advisory boards for Universities around the world and is also a member of the Scientific Advisory Board of the National Cancer Institute. Among his many awards he is the recipient of the George Von Hevesy Prize and the Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science from the Society of Nuclear Medicine, Outstanding Researcher Award from the Radiological Society of Northern America in 2009, the Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation, the Holst Medal, the Tesla Medal, and the Hounsfield Medal from Imperial College, London. He was also elected to the Institute of Medicine of the US National Academies in 2008.
Gary Tearney is a co-inventor of NinePoint Medical’s optical imaging technology. As the associate director of the Wellman Center for Photomedicine at Massachusetts General Hospital and the optical diagnostics program leader at the Center for Integration of Medicine and Innovative Technology, Gary’s research focuses on optical coherence tomography and other imaging modalities. His work has been featured in prestigious journals including Science, Nature, Nature Medicine, Circulation, Gastroenterology, and the Journal of the American College of Cardiology. He is also a professor of pathology at Harvard Medical School and an affiliated faculty member of the Harvard-MIT Division of Health Sciences and Technology. He completed his PhD degree in electrical engineering and computer science at MIT, where he also received postdoctoral training in the application of advanced laser sources in biology and medicine. He received his MD degree from Harvard Medical School and conducted his residency in pathology at Massachusetts General Hospital.
Dr.Jacques Van Dam is a professor of medicine at the University of Southern California and director of clinical gastroenterologyat the USC University Medical Center.Dr. Van Dam’s areas of expertise include pancreatic, esophageal, gastric and colorectal cancer. Dr. Van Dam’s clinical expertise is in diagnostic and therapeutic endoscopy, advanced interventional endoscopy, and advanced endoscopic imaging including microendoscopy and optical biopsy.
Dr. Van Dam completed his Doctor ofMedicine and PhD in physiology and biophysics from Georgetown University School of Medicine. He completed his internship and residency in internal medicine at New England Deaconess Hospital, Harvard Medical School and attained fellowship in Gastroenterology in Beth Israel Hospital, Harvard Medical School.Dr. Van Dam also completed advanced fellowship interventional/therapeutic gastrointestinal endoscopy at The Cleveland Clinic Foundation. He received advanced leadership training in the Stanford Physician Leadership Development Program at Stanford University.